Stories about research and scientific development at Mount Sinai
Two Researchers Receive Robin Chemers Neustein Award
Hélène Salmon, PhD, and Lara Manganaro, PhD, are the recipients of the 2016 Robin Chemers Neustein Postdoctoral Fellowship Award, which was created to encourage and support female research scientists at the Icahn School of Medicine at Mount Sinai. Dr. Salmon works in...
Second-Hand Smoke More Pervasive Than People Think
Many people who are exposed to second-hand cigarette smoke on a day-to-day basis do not realize it, according to newly published research by physicians at the Icahn School of Medicine at Mount Sinai. Yet exposure to this carcinogen carries an increased risk for heart...
Research Reveals New Insights Into the Preclinical Stages of Inflammatory Bowel Disease
Years before inflammatory bowel disease (IBD) is diagnosed and symptoms exist, biomarkers are already circulating that can help predict risk not only of disease development but also of complications, according to recent findings by Mount Sinai scientists and partner...
EANS 2014: Virtual Reality Simulations in Brain Surgery
Mount Sinai’s Neurosurgery team and other presenters pose a critical question: What if your surgeon already did your surgery before you came to the operating room? Neurosurgeons, residents and researchers congregated in the historic city of Prague to discover the...
Advancing Treatment for Rare Endocrine Disorder
Patients and caregivers from around the globe gathered to learn about the latest surgical approaches, including minimally invasive, endoscopic, and robotic techniques, to treat multiple endocrine neoplasia—a rare inherited condition that affects the body's network of...
The Tisch Cancer Institute Receives a $10 Million Grant to Study Acute Graft-Versus-Host Disease
Physician-scientists at The Tisch Cancer Institute have been awarded $10 million from the National Cancer Institute to continue their novel research into therapies that improve the standard of care for patients who develop acute graft-versus-host disease (GVHD)...
Mount Sinai Study Advances the Use of a New Implanted Device to Treat Opioid Addiction
The U.S. Food and Drug Administration, following a nationwide clinical study by researchers at the Mount Sinai Health System, recently approved the first implantable form of buprenorphine—a drug used to treat opioid addiction. The implant, called Probuphine, delivers...
Addressing Health Challenges Fifteen Years After 9/11
Fifteen years after the destruction of the World Trade Center, many first responders continue to grapple with health issues stemming from their work at Ground Zero, including those who report symptoms of posttraumatic stress disorder (PTSD). In a recently published...
Mount Sinai and Stony Brook Form an Affiliation, Building on Strengths in Research and Education
The Icahn School of Medicine at Mount Sinai and the Stony Brook University School of Medicine have entered into an affiliation agreement that will build on a shared “culture of innovation” to enrich academic medicine programs and pursue breakthroughs in treating and...